Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes

Molecular and Cellular Biology

Volumn 22, Issue 1, 2002, Pages 321-331

  Taube, R ^a   Lin, X ^a   Irwin, D ^a   Fujinaga, K ^a   Peterlin, B M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ELONGATION FACTOR; ELONGATION FACTOR B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ARTICLE; BACTERIOPHAGE; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; TRANSCRIPTION REGULATION;

ANIMALS; COS CELLS; CYCLIN-DEPENDENT KINASE 9; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAT; GENES, REPORTER; HELA CELLS; HUMANS; MODELS, GENETIC; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; RNA POLYMERASE II; TRANSCRIPTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036133174     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.1.321-331.2002     Document Type: Article

References (62)

1. NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II
2. Coupling RNA polymerase II transcription with pre-mRNA processing
3. Recruitment of a protein complex containing Tat and cyclin TI to TAR governs the species specificity of HIV-1 Tat
4. Going the distance: A current view of enhancer action
5. Control of elongation by RNA polymerase II
6. Modularity in promoters and enhancers
7. Relief of two built-in autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter
8. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription
9. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat
10. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T
11. HIV-1 Tat: Coping with negative elongation factors
12. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 Tat-P-TEFb complex to TAR RNA
13. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein
14. RNA polymerase II C-terminal domain required for enhancer-driven transcription
15. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR
16. Transcriptional antitermination
17. RNA polymerase II as a control panel for multiple coactivator complexes
18. TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes
19. Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNAPII
20. The SV-40 enhancer: Transcriptional regulation through a hierarchy of combinatorial interactions
21. Domains in the SPT5 protein that modulate its transcriptional regulatory properties
22. Cyclin TI domains involved in complex formation with Tat and TAR RNA
23. Eukaryotic transcriptional regulatory proteins
24. Control of RNA initiation and elongation at the HIV-1 promoter
25. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection
26. Antitermination of transcription within the long terminal repeat of HIV-1 by tat gene product
27. P-TEFb phosphorylates hSPT5 and RNA polymerase II CTD independently of CAK
28. Tat-SF1 protein associates with RAP30 and human SPT5 proteins
29. HIV-1 Tat overcomes inefficient transcriptional elongation in vitro
30. Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation
31. Orchestrated response: A symphony of transcription factors for gene control
32. Promoter-associated pausing in promoter architecture and postinitiation transcriptional regulation
33. P-TEFb kinase recruitment and function at heat shock loci
34. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo
35. Conditional expression of RNA polymerase II in mammalian cells. Deletion of the carboxyl-terminal domain of the large subunit affects early steps in transcription
36. Enhancer sequences and the regulation of gene transcription
37. Transcriptional activity of positive transcription elongation factor b kinase in vivo requires the C-terminal domain of RNA polymerase II
38. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II
39. The general transcription factors of RNA polymerase II
40. NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro
41. Identification of a cyclin subunit required for the function of Drosophila P-TEFb
42. Identification of multiple cyclin subunits of human P-TEFb
43. Oligonucleotide that binds nuclear factor NF-κB acts as a lymphoid-specific and inducible enhancer element
44. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation
45. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II
46. Transcriptional regulation of the Ig kappa gene by promoter-proximal pausing of RNA polymerase II
47. The RNA polymerase II general transcription factors: Past, present, and future
48. Mechanism and regulation of transcriptional elongation by RNA polymerase II
49. C-terminal domain (CTD) of RNA-polymerase II and N-terminal segment of the human TATA binding protein (TBP) can mediate remote and proximal transcriptional activation, respectively
50. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: Is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
51. Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions
52. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro
53. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: Implications for Tat function
54. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
55. Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo
56. Tat transactivation: A model for the regulation of eukaryotic transcriptional elongation
57. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs
58. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro
59. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA
60. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer
61. Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat-activation
62. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation